Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,995 signal articles · 219 in last 24h · 119,250 total before filter · latest 1h ago
219last 24h
1517last 7d
255● bullish (7d)
157● bearish (7d)
205publishers
AllMacro290Earnings596M&A105Regulatory20Product14Analyst21
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
'This was not an exceptional result': Strategist talks AMD earnings & 'shocking' capex
Yahoo Finance Video15d agoneutralVIDEO
'This was not an exceptional result': Strategist talks AMD earnings & 'shocking' capex

AMD (AMD) reported second quarter results on Tuesday after the closing bell. Adjusted earnings per share (EPS) came in at $1.66 (compared to analyst estimates of $1.62), and revenue came in at $11.54 billion (compared to analyst estimates of $11.31 billion).Futurum chief market strategist Shay Boloor shares his thoughts with Yahoo Finance's Josh Lipton.

Bloomberg15d agoneutral
Lucid Plans Business ‘Reset’ to Save $1.4 Billion in Cash

(Bloomberg) -- Lucid Group Inc. is targeting $1.4 billion in cash savings this year as part of a “comprehensive operational reset,” an effort by new Chief Executive Officer Silvio Napoli to shore up the money-losing maker of electric vehicles.Most Read from BloombergBeer Dynasty Families Sell €731 Million Stake in AB InBevChina’s AI Blitz Creates ‘Death Zone’ for Rival US Model MakersTaco Bell Met With Michigan on Parasite Weeks Before RecallIran Weighs Allowing Europe to Clear Mines in Strait o

CVS’s Turnaround Faces Its Next Test
Barrons.com15d agoneutral
CVS’s Turnaround Faces Its Next Test

CVS Health reports earnings Wednesday, with analysts expecting another solid quarter and looking for potential guidance upside from its Aetna insurance and Caremark pharmacy-benefit businesses.